Ausgabe 3/2014
Inhalt (14 Artikel)
MicroRNA-21 in breast cancer: diagnostic and prognostic potential
J. Chen, X. Wang
Recommendations of a group of experts for the pathological assessment of tumour regression of liver metastases of colorectal cancer and damage of non-tumour liver tissue after neoadjuvant therapy
M. L. Gómez Dorronsoro, R. Vera, L. Ortega, C. Plaza, R. Miquel, M. García, E. Díaz, M. R. Ortiz, J. Pérez, C. Hörndler, C. Villar, J. Antúnez, S. Pereira, F. López-Rios, R. González-Cámpora
Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
R. García-Carbonero, F. Vilardell, P. Jiménez-Fonseca, R. González-Campora, E. González, M. Cuatrecasas, J. Capdevila, I. Aranda, J. Barriuso, X. Matías-Guiu
The clinical significance of memory T cells and its subsets in gastric cancer
R. Zhang, F. Li, H. Li, J. Yu, X. Ren
PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer
A. C. Vidal, N. M. Henry, S. K. Murphy, O. Oneko, M. Nye, J. A. Bartlett, F. Overcash, Z. Huang, F. Wang, P. Mlay, J. Obure, J. Smith, B. Vasquez, B. Swai, B. Hernandez, C. Hoyo
Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain
C. Balañá, M. A. Vaz, D. Lopez, R. de la Peñas, J. M. García-Bueno, M. J. Molina-Garrido, J. M. Sepúlveda, J. M. Cano, C. Bugés, S. M. Sanz, J. L. Arranz, P. Perez-Segura, A. Rodriguez, J. M. Martin, M. Benavides, M. Gil
Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)
R. Andrés, I. Pajares, J. Balmaña, G. Llort, T. Ramón y Cajal, I. Chirivella, E. Aguirre, L. Robles, E. Lastra, P. Pérez-Segura, N. Bosch, C. Yagüe, E. Lerma, J. Godino, M. D. Miramar, M. Moros, P. Astier, B. Saez, M. J. Vidal, A. Arcusa, S. Ramón y Cajal, M. T. Calvo, A. Tres
Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer
L. Chen, B. Jiang, Z. Wang, M. Liu, H. Yang, J. Xing, C. Zhang, Z. Yao, N. Zhang, M. Cui, X. Su
HIV-1 viral protein R downregulates Ebp1 and stabilizes p53 in glioblastoma U87MG cells
S. Zhang, B. Zhang, X. Xu, L. Wang, X. Feng, Q. Wang, H. Huang, J. Wu, P. Li, J. Wang
Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain
L. Cerezo, A. de la Torre, A. Hervás, A. Ruiz, O. Liñán, M. López, K. Villar, M. Martín
Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients
X. Li, W. Qi, R. Yao, D. Tang, J. Liang
Microvesicle microRNA profiles and functional roles between chronic hepatitis B and hepatocellular carcinoma
H. Li, L. Sun, X. Chen, W. Xiong, D. Hu, S. Jie
Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours
I. Durán, C. Garzón, A. Sánchez, I. García-Carbonero, J. L. Pérez-Gracia, M. Á. Seguí-Palmer, R. Wei, G. Restovic, J. A. Gasquet, L. Gutiérrez
Changes in the immune cell population and cell proliferation in peripheral blood after gemcitabine-based chemotherapy for pancreatic cancer
Y. Homma, K. Taniguchi, M. Nakazawa, R. Matsuyama, R. Mori, K. Takeda, Y. Ichikawa, K. Tanaka, I. Endo